1
|
Nakahara R, Aki S, Sugaya M, Hirose H, Kato M, Maeda K, Sakamoto DM, Kojima Y, Nishida M, Ando R, Muramatsu M, Pan M, Tsuchida R, Matsumura Y, Yanai H, Takano H, Yao R, Sando S, Shibuya M, Sakai J, Kodama T, Kidoya H, Shimamura T, Osawa T. Hypoxia activates SREBP2 through Golgi disassembly in bone marrow-derived monocytes for enhanced tumor growth. EMBO J 2023; 42:e114032. [PMID: 37781951 PMCID: PMC10646561 DOI: 10.15252/embj.2023114032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 08/22/2023] [Accepted: 08/28/2023] [Indexed: 10/03/2023] Open
Abstract
Bone marrow-derived cells (BMDCs) infiltrate hypoxic tumors at a pre-angiogenic state and differentiate into mature macrophages, thereby inducing pro-tumorigenic immunity. A critical factor regulating this differentiation is activation of SREBP2-a well-known transcription factor participating in tumorigenesis progression-through unknown cellular mechanisms. Here, we show that hypoxia-induced Golgi disassembly and Golgi-ER fusion in monocytic myeloid cells result in nuclear translocation and activation of SREBP2 in a SCAP-independent manner. Notably, hypoxia-induced SREBP2 activation was only observed in an immature lineage of bone marrow-derived cells. Single-cell RNA-seq analysis revealed that SREBP2-mediated cholesterol biosynthesis was upregulated in HSCs and monocytes but not in macrophages in the hypoxic bone marrow niche. Moreover, inhibition of cholesterol biosynthesis impaired tumor growth through suppression of pro-tumorigenic immunity and angiogenesis. Thus, our findings indicate that Golgi-ER fusion regulates SREBP2-mediated metabolic alteration in lineage-specific BMDCs under hypoxia for tumor progression.
Collapse
Affiliation(s)
- Ryuichi Nakahara
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
- Department of Chemistry and Biotechnology, Graduate School of EngineeringThe University of TokyoTokyoJapan
| | - Sho Aki
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
- Department of Chemistry and Biotechnology, Graduate School of EngineeringThe University of TokyoTokyoJapan
| | - Maki Sugaya
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | - Haruka Hirose
- Department of Systems Biology, Graduate School of MedicineNagoya UniversityNagoyaJapan
- Present address:
Department of Computational and Systems Biology, Medical Research InstituteTokyo Medical and Dental UniversityTokyoJapan
| | - Miki Kato
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | - Keisuke Maeda
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | - Daichi M Sakamoto
- Department of Chemistry and Biotechnology, Graduate School of EngineeringThe University of TokyoTokyoJapan
| | - Yasuhiro Kojima
- Department of Systems Biology, Graduate School of MedicineNagoya UniversityNagoyaJapan
| | - Miyuki Nishida
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | - Ritsuko Ando
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | - Masashi Muramatsu
- Division of Molecular and Vascular Biology, IRDAKumamoto UniversityKumamotoJapan
| | - Melvin Pan
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | - Rika Tsuchida
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | | | - Hideyuki Yanai
- Department of Inflammology, RCASTThe University of TokyoTokyoJapan
| | - Hiroshi Takano
- Department of Cell BiologyJapanese Foundation for Cancer ResearchTokyoJapan
| | - Ryoji Yao
- Department of Cell BiologyJapanese Foundation for Cancer ResearchTokyoJapan
| | - Shinsuke Sando
- Department of Chemistry and Biotechnology, Graduate School of EngineeringThe University of TokyoTokyoJapan
- Department of Bioengineering, Graduate School of EngineeringThe University of TokyoTokyoJapan
| | - Masabumi Shibuya
- Institute of Physiology and MedicineJobu UniversityTakasakiJapan
| | - Juro Sakai
- Division of Metabolic Medicine, RCASTThe University of TokyoTokyoJapan
- Division of Molecular Physiology and Metabolism, Graduate School of MedicineTohoku UniversitySendaiJapan
| | - Tatsuhiko Kodama
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
| | - Hiroyasu Kidoya
- Department of Signal Transduction, RIMDOsaka UniversityOsakaJapan
- Department of Integrative Vascular Biology, Faculty of Medical SciencesUniversity of FukuiFukuiJapan
| | - Teppei Shimamura
- Department of Systems Biology, Graduate School of MedicineNagoya UniversityNagoyaJapan
- Present address:
Department of Computational and Systems Biology, Medical Research InstituteTokyo Medical and Dental UniversityTokyoJapan
| | - Tsuyoshi Osawa
- Division of Nutriomics and Oncology, RCASTThe University of TokyoTokyoJapan
- Department of Chemistry and Biotechnology, Graduate School of EngineeringThe University of TokyoTokyoJapan
| |
Collapse
|
2
|
Cha J, Hong S, Lee J, Gwak J, Kim M, Mok S, Moon HB, Jones PD, Giesy JP, Khim JS. Identification of Mid-Polar and Polar AhR Agonists in Cetaceans from Korean Coastal Waters: Application of Effect-Directed Analysis with Full-Scan Screening. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2023; 57:15644-15655. [PMID: 37787753 PMCID: PMC10586376 DOI: 10.1021/acs.est.3c04311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Revised: 09/16/2023] [Accepted: 09/18/2023] [Indexed: 10/04/2023]
Abstract
Major aryl hydrocarbon receptor (AhR) agonists were identified in extracts of blubber, liver, and muscle from six long-beaked common dolphins (Delphinus capensis) and one fin whale (Balaenoptera physalus) collected from Korean coastal waters using effect-directed analysis. Results of the H4IIE-luc bioassay indicated that the polar fractions of blubber and liver extracts from the fin whale exhibited relatively high AhR-mediated potencies. Based on full-scan screening with high-resolution mass spectrometry, 37 AhR agonist candidates, spanning four use categories: pharmaceuticals, pesticides, cosmetics, and natural products, were selected. Among these, five polar AhR agonists were newly identified through toxicological confirmation. Concentrations of polar AhR agonists in cetaceans were tissue-specific, with extracts of blubber and liver containing greater concentrations than muscle extracts. Polar AhR agonists with great log KOA values (>5) were found to biomagnify in the marine food chain potentially. Polar AhR agonists contributed 8.9% of the observed AhR-mediated potencies in blubber and 49% in liver. Rutaecarpine and alantolactone contributed significantly to the total AhR-mediated potencies of blubber, whereas hydrocortisone was a major AhR contributor in the liver of the fin whale. This study is the first to identify the tissue-specific accumulation of polar AhR agonists in blubber and liver extracts of cetaceans.
Collapse
Affiliation(s)
- Jihyun Cha
- Department
of Marine Environmental Science, Chungnam
National University, Daejeon 34134, Republic
of Korea
| | - Seongjin Hong
- Department
of Marine Environmental Science, Chungnam
National University, Daejeon 34134, Republic
of Korea
| | - Junghyun Lee
- School
of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea
- Department
of Environmental Education, Kongju National
University, Gongju 32588, Republic of Korea
| | - Jiyun Gwak
- Department
of Marine Environmental Science, Chungnam
National University, Daejeon 34134, Republic
of Korea
| | - Mungi Kim
- Department
of Marine Environmental Science, Chungnam
National University, Daejeon 34134, Republic
of Korea
| | - Sori Mok
- Department
of Marine Science and Convergence Engineering, Hanyang University, Ansan 15588, Republic
of Korea
| | - Hyo-Bang Moon
- Department
of Marine Science and Convergence Engineering, Hanyang University, Ansan 15588, Republic
of Korea
| | - Paul D. Jones
- Department
of Veterinary Biomedical Sciences & Toxicology Centre, University of Saskatchewan, Saskatoon, Saskatchewan S7N5B3, Canada
| | - John P. Giesy
- Department
of Veterinary Biomedical Sciences & Toxicology Centre, University of Saskatchewan, Saskatoon, Saskatchewan S7N5B3, Canada
- Department
of Integrative Biology and Institute for Integrative Toxicology, Michigan State University, East Lansing, Michigan 48824, United States
- Department
of Environmental Science, Baylor University, Waco, Texas 76798-7266, United States
| | - Jong Seong Khim
- School
of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea
| |
Collapse
|
3
|
Cha J, Hong S, Gwak J, Kim M, Lee J, Kim T, Han GM, Hong SH, Hur J, Giesy JP, Khim JS. Identification of novel polar aryl hydrocarbon receptor agonists accumulated in liver of black-tailed gulls in Korea using advanced effect-directed analysis. JOURNAL OF HAZARDOUS MATERIALS 2022; 429:128305. [PMID: 35077967 DOI: 10.1016/j.jhazmat.2022.128305] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Revised: 01/04/2022] [Accepted: 01/17/2022] [Indexed: 06/14/2023]
Abstract
Although bioaccumulation of persistent organic pollutants in seabirds has been examined, few studies have been conducted to identify previously unidentified substances. Here, aryl hydrocarbon receptor (AhR) agonists were identified in livers of black-tailed gulls from South Korea using effect-directed analysis combined with full-scan screening analysis. Significant AhR-mediated potencies were observed in the polar fractions of liver extracts using H4IIE-luc bioassay. Eight known polar AhR agonists accounted for 11-20% of the total AhR-mediated potencies in the polar fractions; hydrocortisone and rutaecarpine were the major contributors. Twenty-two AhR agonist candidates in the polar fractions were identified using liquid chromatography-quadrupole time-of-flight mass spectrometry during a six-step selection process. Of these, [10]-gingerol, angelicin, corticosterone, eupatilin, etofenprox, oxadixyl, and tretinoin were identified as novel AhR agonists. The contribution to potencies increased with inclusion of novel AhR agonists (27-52%); corticosterone and [10]-gingerol contributed significantly. Quantitative structure-activity relationship suggested that the novel AhR agonists have other potential toxic effects, including carcinogenicity and mutagenicity. Polar AhR agonists have been used for pharmaceuticals and pesticides. Some novel AhR agonists have log KOW > 2 and log KOA ≥ 6, which indicates that these compounds can be biomagnified in air-breathing organisms, such as seabirds.
Collapse
Affiliation(s)
- Jihyun Cha
- Department of Marine Environmental Science, Chungnam National University, Daejeon 34134, Republic of Korea
| | - Seongjin Hong
- Department of Marine Environmental Science, Chungnam National University, Daejeon 34134, Republic of Korea.
| | - Jiyun Gwak
- Department of Marine Environmental Science, Chungnam National University, Daejeon 34134, Republic of Korea
| | - Mungi Kim
- Department of Marine Environmental Science, Chungnam National University, Daejeon 34134, Republic of Korea
| | - Junghyun Lee
- School of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea
| | - Taewoo Kim
- School of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea
| | - Gi Myung Han
- Oil and POPs Research Group, Korea Institute of Ocean Science and Technology, Geoje 53201, Republic of Korea
| | - Sang Hee Hong
- Oil and POPs Research Group, Korea Institute of Ocean Science and Technology, Geoje 53201, Republic of Korea; Department of Ocean Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea
| | - Jin Hur
- Department of Environment and Energy, Sejong University, Seoul 05006, Republic of Korea
| | - John P Giesy
- Department of Veterinary Biomedical Sciences & Toxicology Centre, University of Saskatchewan, Saskatoon, SK S7N5B3, Canada; Department of Environmental Science, Baylor University, Waco, TX 76798-7266, United States
| | - Jong Seong Khim
- School of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea.
| |
Collapse
|
4
|
Panda MK, Paul M, Singdevsachan SK, Tayung K, Das SK, Thatoi H. Promising Anti-cancer Therapeutics From Mushrooms: Current Findings and Future Perceptions. Curr Pharm Biotechnol 2021; 22:1164-1191. [PMID: 33032507 DOI: 10.2174/1389201021666201008164056] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Revised: 09/02/2020] [Accepted: 09/03/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Nowadays, medicines derived from natural sources have drawn much attention as potential therapeutic agents in the suppression and treatment of cancer because of their low toxicity and fewer side effects. OBJECTIVE The present review aims to assess the currently available knowledge on the ethnomedicinal uses and pharmacological activities of bioactive compounds obtained from medicinal mushrooms towards cancer treatment. METHODS A literature search has been conducted for the collection of research papers from universally accepted scientific databases. These research papers and published book chapters were scrutinized to retrieve information on ethnomedicinal uses of mushrooms, different factors involved in cancer cell proliferation, clinical and in silico pharmaceutical studies made for possible treatments of cancer using mushroom derived compounds. Overall, 241 articles were retrieved and reviewed from the year 1970 to 2020, out of which 98 relevant articles were finally considered for the preparation of this review. RESULTS This review presents an update on the natural bioactive substances derived from medicinal mushrooms and their role in inhibiting the factors responsible for cancer cell proliferation. Along with it, the present review also provides information on the ethnomedicinal uses, solvents used for extraction of anti-cancer metabolites, clinical trials, and in silico studies that were undertaken towards anticancer drug development from medicinal mushrooms. CONCLUSION The present review provides extensive knowledge on various anti-cancer substances obtained from medicinal mushrooms, their biological actions, and in silico drug designing approaches, which could form a basis for the development of natural anti-cancer therapeutics.
Collapse
Affiliation(s)
- Mrunmaya K Panda
- Department of Biotechnology, North Orissa University, Baripada-757003, Odisha, India
| | - Manish Paul
- Department of Biotechnology, North Orissa University, Baripada-757003, Odisha, India
| | - Sameer K Singdevsachan
- Spinco Biotech Pvt. Ltd., Spinco Towers, No. 934, 5th A cross, Service Road, HRBR Layout 1st Block, Kalyan Nagar, Bengaluru-560043, Karnataka, India
| | - Kumananda Tayung
- Department of Botany, Gauhati University, Gopinath Bordoloi Nagar, Guwahati-781014, Assam, India
| | - Swagat K Das
- Department of Biotechnology, College of Engineering and Technology, Biju Patnaik University of Technology, Bhubaneswar- 751003, Odisha, India
| | - Hrudayanath Thatoi
- Department of Biotechnology, North Orissa University, Baripada-757003, Odisha, India
| |
Collapse
|
5
|
Cha J, Hong S, Lee J, Gwak J, Kim M, Kim T, Hur J, Giesy JP, Khim JS. Novel polar AhR-active chemicals detected in sediments of an industrial area using effect-directed analysis based on in vitro bioassays with full-scan high resolution mass spectrometric screening. THE SCIENCE OF THE TOTAL ENVIRONMENT 2021; 779:146566. [PMID: 34030261 DOI: 10.1016/j.scitotenv.2021.146566] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2020] [Revised: 02/22/2021] [Accepted: 03/14/2021] [Indexed: 06/12/2023]
Abstract
Studies investigating aryl hydrocarbon receptor (AhR)-active compounds in the environment typically focus on non- and mid-polar substances, such as PAHs; while, information on polar AhR agonists remains limited. Here, we identified polar AhR agonists in sediments collected from the inland creeks of an industrialized area (Lake Sihwa, Korea) using effect-directed analysis combined with full-scan screening analysis (FSA; using LC-QTOFMS). Strong AhR-mediated potencies were observed for the polar and latter fractions of RP-HPLC (F3.5-F3.8) from sediment organic extracts in the H4IIE-luc in vitro bioassays. FSA was performed on the corresponding fractions. Twenty-eight tentative AhR agonists were chosen using a five-step process. Toxicological confirmation using bioassay revealed that canrenone, rutaecarpine, ciprofloxacin, mepanipyrim, genistein, protopine, hydrocortisone, and medroxyprogesterone were significantly active. The relative potencies of these AhR-active compounds compared to that of benzo[a]pyrene ranged from 0.00002 to 2.0. Potency balance analysis showed that polar AhR agonists explained, on average, ~6% of total AhR-mediated potencies in samples. Some novel polar AhR agonists also exhibited endocrine-disrupting potentials capable of binding to estrogen and glucocorticoid receptors, as identified by QSAR modeling. In conclusion, the focused studies on distributions, sources, fate, and ecotoxicological effects of novel polar AhR agonists in the environment are necessary.
Collapse
Affiliation(s)
- Jihyun Cha
- Department of Ocean Environmental Sciences, Chungnam National University, Daejeon 34134, Republic of Korea
| | - Seongjin Hong
- Department of Ocean Environmental Sciences, Chungnam National University, Daejeon 34134, Republic of Korea.
| | - Junghyun Lee
- School of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea
| | - Jiyun Gwak
- Department of Ocean Environmental Sciences, Chungnam National University, Daejeon 34134, Republic of Korea
| | - Mungi Kim
- Department of Ocean Environmental Sciences, Chungnam National University, Daejeon 34134, Republic of Korea
| | - Taewoo Kim
- School of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea
| | - Jin Hur
- Department of Environment & Energy, Sejong University, Seoul 05006, Republic of Korea
| | - John P Giesy
- Department of Veterinary Biomedical Sciences & Toxicology Centre, University of Saskatchewan, Saskatoon, Saskatchewan S7N5B3, Canada; Department of Environmental Science, Baylor University, Waco, TX 76798-7266, United States
| | - Jong Seong Khim
- School of Earth and Environmental Sciences & Research Institute of Oceanography, Seoul National University, Seoul 08826, Republic of Korea.
| |
Collapse
|
6
|
Haag B, Mosrin M, Ila H, Malakhov V, Knochel P. Regio- and Chemoselective Metalation of Arenes and Heteroarenes Using Hindered Metal Amide Bases. Angew Chem Int Ed Engl 2011; 50:9794-824. [DOI: 10.1002/anie.201101960] [Citation(s) in RCA: 324] [Impact Index Per Article: 24.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2011] [Indexed: 11/08/2022]
|
7
|
Haag B, Mosrin M, Ila H, Malakhov V, Knochel P. Regio- und chemoselektive Metallierung von Arenen und Heteroarenen mit gehinderten Metallamidbasen. Angew Chem Int Ed Engl 2011. [DOI: 10.1002/ange.201101960] [Citation(s) in RCA: 130] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
8
|
Mosrin M, Knochel P. Regio- and Chemoselective Metalation of Chloropyrimidine Derivatives with TMPMgCl⋅LiCl and TMP2Zn⋅2 MgCl2⋅2 LiCl. Chemistry 2009; 15:1468-77. [DOI: 10.1002/chem.200801831] [Citation(s) in RCA: 100] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
9
|
Köller W, Wilcox WF, Parker DM. Sensitivity of Venturia inaequalis Populations to Anilinopyrimidine Fungicides and Their Contribution to Scab Management in New York. PLANT DISEASE 2005; 89:357-365. [PMID: 30795450 DOI: 10.1094/pd-89-0357] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Sensitivities of Venturia inaequalis isolates to the anilinopyrimidine fungicides (APs) pyrimethanil and cyprodinil were determined for nine populations by measuring the growth of colonies formed from germinating conidia derived from single scab lesions. At the discriminatory pyrimethanil dose of 0.2 μg ml-1, the mean relative growth range measured for eight V. inaequalis populations (n = 39 to 74) never treated with AP fungicides varied from 18.1 to 48.2, translating into an approximately sixfold difference in mean baseline sensitivities. For the composite of all 469 isolates tested, sensitivities to pyrimethanil and to the sterol demethylation inhibitor (DMI) myclobutanil were significantly correlated. When isolates were organized into subpopulations based on their sensitivities to an individual fungicide, sensitivities to both fungicides declined in parallel through the highly and moderately sensitive spectra of subpopulations, but they diverged for isolates in subpopulations least sensitive to either fungicide. The result suggested that at least one of the multiple genes conferring DMI resistance also lowered the sensitivity to AP fungicides. The relative contribution of AP fungicides to scab management was evaluated at an experimental orchard representative of the Great Lakes region of the United States. Frequencies of DMI-resistant isolates of V. inaequalis had progressed to the stage of practical resistance at the site, and the sensitivity to pyrimethanil was similar to several commercial orchard populations never treated with APs. For management programs at the experimental site involving the AP fungicides cyprodinil and pyrimethanil and conducted from 1996 to 2000, the level of fruit and terminal leaf scab control was inferior to that of nonspecific protectants such as mancozeb or captan. For the control of scab on cluster leaves, the efficacy of AP fungicides equaled the performance of nonspecific protectants. This modest contribution of AP fungicides to scab management might have been caused by a lack of the extended cool temperature conditions that were conducive to AP performance in northern Europe in previous studies, and/or by the reduced sensitivity to AP fungicides in this DMI-resistant V. inaequalis population.
Collapse
Affiliation(s)
- Wolfram Köller
- Department of Plant Pathology, Cornell University, New York State Agricultural Experiment Station, Geneva 14456
| | - W F Wilcox
- Department of Plant Pathology, Cornell University, New York State Agricultural Experiment Station, Geneva 14456
| | - D M Parker
- Department of Plant Pathology, Cornell University, New York State Agricultural Experiment Station, Geneva 14456
| |
Collapse
|